Neogen Chemicals Q1 FY27: Profit up 67%, OPM near 19%

Key takeaway for investors

Neogen Chemicals reported a strong Q1 FY27 set of numbers, led by a sharp jump in profit and a material improvement in operating margins. Consolidated revenue from operations rose to ₹250.29 crore, while profit after tax (PAT) increased to ₹17.11 crore. Operating margin expanded to about 19.3%, the highest level in at least eight quarters, reflecting better product mix and improved operating efficiencies.

But the quarter also underlined the constraints on capital efficiency. Interest costs stayed high at ₹20.81 crore, continuing to absorb a large part of operating profit. Analysts tracking the stock have flagged elevated debt levels and weakening capital efficiency metrics, keeping the rating at HOLD despite the headline beat.

What the company reported for Q1 FY27

Neogen Chemicals Limited (CIN: L24200MH1989PLC050919) disclosed unaudited consolidated financial results for the quarter ended June 30, 2026. On a year-on-year basis, the company delivered strong growth in operating revenue and profitability. Total income rose to ₹254.15 crore in Q1 FY27, up 35.25% from ₹187.91 crore in Q1 FY26.

Revenue from operations stood at ₹250.29 crore, a 34.04% increase over ₹186.73 crore in Q1 FY26. On a sequential basis, revenue rose 1.51% from ₹246.56 crore in Q4 FY26, indicating continued momentum but at a slower pace than the prior quarter’s step-up. Other income rose to ₹3.86 crore in Q1 FY27 from ₹0.98 crore in Q4 FY26 and ₹1.18 crore in Q1 FY26.

Profitability: margins improve, but finance costs remain a drag

Operating profit (PBDIT excluding other income) was reported at ₹48.23 crore, translating into an operating margin of 19.27% for the quarter. Separately, the results note also referenced an operating margin of 19.35% for Q1 FY27, compared with 17.82% in Q4 FY26, indicating broadly the same improvement in operating performance. The quarter’s operating margin was described as the highest in at least eight quarters, supported by favourable product mix and operating efficiencies.

PAT margin rose to 6.84%, improving from 4.62% sequentially and 5.49% in the year-ago period. Profit before tax (PBT) increased to ₹23.28 crore, up 62.91% year-on-year from ₹14.29 crore, and up 46.88% quarter-on-quarter from ₹15.85 crore.

The key constraint remained finance costs. Interest expense was ₹20.81 crore in Q1 FY27, marginally lower than ₹21.47 crore in Q4 FY26, but still large relative to operating profits. This is one of the reasons the earnings uplift has not translated into stronger capital efficiency metrics.

Costs, employee expenses, and tax profile

Total consolidated expenses were ₹231.07 crore in Q1 FY27, up 33.05% from ₹173.67 crore in Q1 FY26 and broadly flat compared with ₹231.72 crore in Q4 FY26. The company cited higher employee costs as a partial offset to the operating leverage benefits. Employee costs rose to ₹25.30 crore from ₹19.57 crore year-on-year.

Tax expense for the quarter stood at ₹6.17 crore, comprising current tax of ₹6.03 crore and deferred tax of ₹0.14 crore. The effective tax rate was stated at 26.50%, down from 28.14% in the prior quarter. PAT for Q1 FY27 rose 66.76% year-on-year to ₹17.11 crore from ₹10.26 crore, and increased 50.22% sequentially from ₹11.39 crore.

Standalone numbers and the QIP fundraising plan

Alongside consolidated performance, market commentary also highlighted standalone results and corporate actions. Standalone net profit for the quarter ended June 30, 2026, was reported at ₹19.40 crore, up about 36.62% year-on-year from ₹14.20 crore. Standalone revenue from operations was reported at ₹252.00 crore, up 40% year-on-year from ₹180.00 crore.

Neogen’s board approved raising up to ₹600 crore through a Qualified Institutional Placement (QIP) route. The update also noted that a credit rating downgrade resulted in a higher NCD coupon rate, reinforcing investor focus on balance sheet and funding costs.

Dahej plant fire: insurance recoveries and operations update

The company received an additional ₹15.00 crore towards the fourth on-account insurance payment for the Dahej SEZ fire incident, received on July 16, 2026. Total on-account claim received to date reached ₹155.00 crore. The payment covers loss of property, plant, and equipment based on surveyors’ recommendations.

The affected MPP3 facility remained temporarily suspended, while construction of a replacement plant was stated to be progressing rapidly with commissioning scheduled for H1 FY27. To reduce disruption, the company shifted production of select critical specialty products to other sites with customer approval and continued with a planned expansion at its Patancheru plant.

Capital efficiency and why analysts remain cautious

Despite improved operating performance, the company’s return on equity (ROE) was described as meagre, averaging 6.86% and substantially below industry standards. The same commentary flagged weakening capital efficiency metrics and elevated debt levels, which have contributed to a HOLD stance from analysts tracking the stock.

In practical terms, the Q1 FY27 outcome shows operating leverage is improving, but the overall return profile is still constrained by financing costs and capital intensity. Interest expense of ₹20.81 crore, against operating profit of ₹48.23 crore, highlights how quickly higher funding costs can limit the flow-through from margins to net profit.

Conference call and market references

Neogen Chemicals scheduled its Q1 FY27 earnings conference call for Monday, July 27, 2026 at 4:00 PM IST. Management is expected to discuss quarterly results and provide updates on key capital expenditure developments.

Separately, the provided market data referenced price levels of 2,152.00 and 2,331.90, though no further context was included alongside these levels.

Financial snapshot (consolidated and standalone)

Longer-term context from FY26 disclosures

For FY26, consolidated revenue from operations was disclosed at ₹861.96 crore, up 10.85% from ₹777.56 crore in FY25. Another figure cited for FY26 consolidated revenue was ₹862.00 crore, described as an 11% increase over FY25. These numbers provide context to the Q1 FY27 run-rate, especially as the company works through capacity restoration and ongoing capex revisions discussed in recent disclosures.

Conclusion

Neogen Chemicals’ Q1 FY27 results show strong year-on-year revenue growth, a sharp increase in PAT, and operating margins near 19.3%, the best in several quarters. At the same time, high interest costs, elevated debt concerns, and a low average ROE of 6.86% keep focus on capital efficiency rather than only near-term earnings momentum. The next immediate checkpoint is the July 27, 2026 earnings call, where investors will look for updates on capex plans, funding strategy including the proposed ₹600 crore QIP, and the commissioning timeline for the Dahej replacement facility in H1 FY27.